Company
Headquarters: Shanghai, China
Employees: 2,661
CN¥11.01 Billion
CNY as of Jan. 1, 2025
US$1.51 Billion
Company | Market Cap (USD) |
---|---|
Intuitive | $216.79 B |
EssilorLuxottica SA | $116.96 B |
Becton, Dickinson and Company | $69.74 B |
HOYA Corp | $45.26 B |
Alcon Inc. | $41.55 B |
Company | Market Cap (USD) |
---|---|
Lilly | $689.42 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $487.54 B |
Johnson & Johnson | $353.05 B |
AbbVie | $301.60 B |
Tofflon Science and Technology Group Co., Ltd. operates as a pharmaceutical equipment supplier for the pharma and biotech industries worldwide. It offers injectables, such as auto solution preparation systems, aseptic filling lines for ampoule, vials, syringes and powders, freeze dryer and auto loading systems, barrier systems, and plastic packaging machines. The company also provides active pharmaceutical ingredients; and visual inspection, leak detection, and combination systems, as well as focuses on providing bio-process equipment and integrated systems, including medium preparation, cell/microbial cultivation, harvesting, DF/UF, purification, buffer preparation, and finished filling systems. In addition, it offers lyophilization injectable lab services. The company was formerly known as Shanghai Tofflon Science and Technology Co., Ltd. The company was founded in 1993 and is headquartered in Shanghai, China.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Last Financial Reports Date | Sept. 30, 2024 |
Revenue TTM | CN¥4.81 B |
EBITDA | CN¥884.4 M |
Gross Profit TTM | CN¥1.99 B |
Profit Margin | 3.53% |
Operating Margin | 6.42% |
Quarterly Revenue Growth | -12.80% |
Shanghai Tofflon Science and Technology Co. Ltd has the following listings and related stock indices.
Stock: SZSE: 300171 wb_incandescent